Showing results (221-230 of 1,689) with videos related to

Sort By:
Pageof 169
Cancer|January 28, 2009
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomyMin Yi, Funda Meric-Bernstam, Lavinia P Middleton, et al.
JAMA Network Open|March 6, 2020
Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy SpecimensSavitri Krishnamurthy, Sharjeel Sabir, Kechen Ban, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2015
Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancerEnrique Sanz-Garcia, Tamara Saurí, Josep Tabernero, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 9, 2012
[Neuroendocrine tumors: the age of targeted therapies]Jaume Capdevila, Guillem Argilés, Nuria Mulet-Margalef, et al.
Advances in Clinical Chemistry|September 23, 2010
EGFR and KRAS in colorectal cancerBen Markman, Francisco Javier Ramos, Jaume Capdevila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2019
Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR TrialEric Van Cutsem, Caroline Paccard, Marielle Chiron, et al.
Targeted Oncology|November 12, 2009
Targeted therapies in thyroid cancerJaume Capdevila, Jose Perez-Garcia, Gabriel Obiols, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
SEOM clinical guidelines for the treatment of pancreatic cancerCarlos Gómez-Martín, Manuel Hidalgo, Josep Tabernero, et al.
Molecular Oncology|December 23, 2011
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancerRodrigo Dienstmann, Sara De Dosso, Enriqueta Felip, et al.
Annals of Surgical Oncology|September 5, 2023
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?Clara Farley, Roland Bassett, Funda Meric-Bernstam, et al.
Pageof 169